Gossamer Bio, Inc. GOSS
NASDAQ · United States · Health Technology
$10.93-0.92 (-7.76%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -6.40 | -9.87 | +35.2% | $9.24M | +154.6% | -13.5%$14.24→$12.32 |
| Q1 2026 | 2026-05-15 | -16.00 | -13.64 | -17.3% | — | — | -41.5%$26.40→$15.44 |
| Q4 2025 | 2026-03-17 | -16.80 | -15.65 | -7.3% | — | — | -4.8%$36.48→$34.72 |
| Q3 2025 | 2025-11-05 | -16.80 | -15.77 | -6.5% | — | — | +0.4%$184.00→$184.80 |
| Q2 2025 | 2025-08-05 | -13.60 | -14.44 | +5.8% | — | — | — |
| Q1 2025 | 2025-05-15 | -12.80 | -15.28 | +16.2% | — | — | — |
| Q4 2024 | 2025-03-13 | -12.00 | -13.44 | +10.7% | — | — | — |
| Q3 2024 | 2024-11-07 | -11.20 | -11.55 | +3.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.